Cue Biopharma grants CEO stock options for 655,074 shares at $30.42 each

Cue Biopharma, Inc.

Cue Biopharma, Inc.

CUE

0.00
  • Cue Biopharma granted inducement equity awards May 3, 2026 to seven new employees, including newly appointed president and CEO Shao-Lee Lin.
  • Lin received non-statutory stock options for 655,074 shares at USD 30.42 per share, vesting monthly over four years from her start date.
  • Lin also received restricted stock units covering 327,537 shares, fully vested on grant.
  • Six other new hires received stock options for 518,599 shares at USD 30.42 per share, vesting quarterly over four years.
  • Those employees also received restricted stock units for 327,534 shares, fully vested on grant.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cue Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605071907PRIMZONEFULLFEED9716184) on May 07, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.